Advertisement
Canada markets open in 1 hour 12 minutes
  • S&P/TSX

    24,822.54
    +132.04 (+0.53%)
     
  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     
  • DOW

    43,275.91
    +36.81 (+0.09%)
     
  • CAD/USD

    0.7237
    -0.0011 (-0.15%)
     
  • CRUDE OIL

    70.60
    +1.38 (+1.99%)
     
  • Bitcoin CAD

    94,293.11
    -252.55 (-0.27%)
     
  • XRP CAD

    0.77
    +0.02 (+2.34%)
     
  • GOLD FUTURES

    2,748.40
    +18.40 (+0.67%)
     
  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ futures

    20,362.00
    -121.50 (-0.59%)
     
  • VOLATILITY

    19.17
    +1.14 (+6.33%)
     
  • FTSE

    8,334.69
    -23.56 (-0.28%)
     
  • NIKKEI 225

    38,954.60
    -27.15 (-0.07%)
     
  • CAD/EUR

    0.6665
    -0.0001 (-0.02%)
     

ResMed: Fiscal Q4 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal fourth-quarter earnings of $292.2 million.

The San Diego-based company said it had net income of $1.98 per share. Earnings, adjusted for one-time gains and costs, came to $2.08 per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $2.03 per share.

The maker of medical products for respiratory disorders posted revenue of $1.22 billion in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $1.21 billion.

For the year, the company reported profit of $1.02 billion, or $6.92 per share. Revenue was reported as $4.69 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RMD at https://www.zacks.com/ap/RMD